ATS To Acquire Biomedical Research & Life Sciences Water Purification Equipment Provider Avidity Science

About this update from Ats Corporation

[{"type":"text","content":"\n \n \n \n ATS To Acquire Biomedical Research & Life Sciences Water Purification Equipment Provider Avidity Science\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen5{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prngen6{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prngen3{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 0.5pt solid; BORDER-LEFT:black 1pt\n}\n.prngen4{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 0.5pt solid; BORDER-LEFT:black 1pt\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n \n \n \n \n \n ATS To Acquire Biomedical Research & Life Sciences Water Purification Equipment Provider Avidity Science\n \n \n Canada NewsWire\n \n \n \n \n \n \n CAMBRIDGE, ON\n \n \n ,\n \n \n Sept. 22, 2023\n \n \n /CNW/ - ATS Corporation (TSX: ATS) (NYSE: ATS) (\"\n \n ATS\n \n \" or the \"\n \n Company\n \n \") a leading automation solutions provider, today announced it has entered into a definitive agreement to acquire  Avidity Science, LLC (\"\n \n Avidity\n \n \"), a growing designer and manufacturer of automated water purification solutions for biomedical and life science applications, for\n \n US$195 million\n \n (\n \n ~C$265 million\n \n ), representing 11.2x Avidity's projected calendar 2023 adjusted EBITDA\n \n 1,2\n \n , or 10.3x Avidity's projected calendar 2023 synergy-adjusted EBITDA\n \n 1,2\n \n . The Company expects\n \n US...

More updates from Ats Corporation